Compare studies and check their requirements with the research team.
This study is completed in the United States. It is testing ketamine for treatment-resistant depression.
In United StatesThis study was terminated in the United States. It focuses on Depression.
In United States
This study is completed in the United States. It is testing label Compliance for ADHD.
In United StatesThis study was terminated in the United States, in Mexico, in Russia, .... It is testing LY2140023 for schizophrenia.
In United StatesThis study is completed in the United States, in Israel, in Italy, .... It is testing LY2140023 for schizophrenia.
In United StatesThis study was terminated in the United States. It is testing mifepristone for depression.
In United StatesThis study is completed in the United States. It is testing MK-5720 for schizophrenia.
In United States
This study is enrolling by invitation in the United States. It is testing Moral Distress, Moral Injury and Post-Traumatic Stress for PTSD.
In United StatesThis study was terminated in the United States and in Canada. It is testing MP-101 for Schizophrenia.
In United StatesThis study is completed in the United States, in Colombia, in Malaysia, .... It is testing Paliperidone Palmitate 3 Month Formulation for schizophrenia.
In United StatesThis study is completed in the United States, in Australia, in France, .... It focuses on Schizophrenia.
In United StatesThis study is completed in the United States. It is testing PDC-1421 Treatment for ADHD.
In United StatesHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.